Lung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. For ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

Survival outcomes favored the higher dose: more than 93% of patients in the 70 Gy group were alive one year after treatment, ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Lung cancer is the leading cause of cancer death in Western Australia, and is also the most common and one of the least ...

Breast cancer is the most common type of cancer in women, while prostate, which President Joe Biden was just diagnosed with, is most common for men.

People in the UK and more likely to get cancer than 50 years ago but less likely to die from it, Cancer Research UK says.1 ...

A new blood test will be offered to lung cancer patients in a move that NHS England says will benefit about 15,000 people ...

The FDA has accepted and granted priority review to an NDA for sevabertinib in previously treated HER2+ non-small cell lung ...